Stifel Financial Corp Clearside Biomedical, Inc. Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

A detailed history of Stifel Financial Corp transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 22,944 shares of CLSD stock, worth $25,008. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,944

Previous 30,544 24.88%

Holding current value

$25,008

Previous $39,000 25.64%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.93 - $1.35 $7,068 - $10,260	-7,600 Reduced 24.88%	22,944 $29,000
Q2 2024 Aug 13, 2024	SELL	$1.08 - $1.58 $9,180 - $13,430	-8,500 Reduced 21.77%	30,544 $39,000
Q1 2024 May 13, 2024	BUY	$1.2 - $2.02 $6,000 - $10,100	5,000 Added 14.69%	39,044 $59,000
Q4 2023 Feb 12, 2024	SELL	$0.68 - $1.18 $13,260 - $23,010	-19,500 Reduced 36.42%	34,044 $39,000
Q3 2023 Nov 13, 2023	SELL	$0.82 - $1.27 $5,740 - $8,890	-7,000 Reduced 11.56%	53,544 $46,000
Q2 2023 Aug 14, 2023	BUY	$0.97 - $1.48 $46,379 - $70,764	47,814 Added 375.6%	60,544 $67,000
Q1 2023 May 12, 2023	BUY	$0.93 - $1.66 $465 - $830	500 Added 4.09%	12,730 $13,000
Q4 2022 Feb 13, 2023	SELL	$1.0 - $1.5 $1,500 - $2,250	-1,500 Reduced 10.92%	12,230 $13,000
Q3 2022 Nov 14, 2022	SELL	$1.08 - $1.83 $2,160 - $3,660	-2,000 Reduced 12.71%	13,730 $16,000
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.49 $2,275 - $4,357	-1,750 Reduced 10.01%	15,730 $23,000
Q1 2022 May 13, 2022	SELL	$1.35 - $2.88 $2,700 - $5,760	-2,000 Reduced 10.27%	17,480 $40,000
Q4 2021 Feb 14, 2022	BUY	$2.72 - $5.72 $11,832 - $24,882	4,350 Added 28.75%	19,480 $54,000
Q3 2021 Nov 15, 2021	BUY	$4.83 - $7.2 $3,071 - $4,579	636 Added 4.39%	15,130 $91,000
Q2 2021 Aug 13, 2021	SELL	$2.32 - $5.38 $9,860 - $22,865	-4,250 Reduced 22.67%	14,494 $71,000
Q1 2021 May 14, 2021	BUY	$2.24 - $4.25 $10,640 - $20,187	4,750 Added 33.94%	18,744 $46,000
Q4 2020 Feb 12, 2021	BUY	$1.32 - $2.74 $66 - $137	50 Added 0.36%	13,994 $38,000
Q3 2020 Nov 16, 2020	SELL	$1.45 - $2.0 $5,800 - $8,000	-4,000 Reduced 22.29%	13,944 $21,000
Q2 2020 Aug 14, 2020	BUY	$1.55 - $2.41 $7,663 - $11,915	4,944 Added 38.03%	17,944 $34,000
Q4 2019 Feb 13, 2020	SELL	$0.62 - $3.4 $1,860 - $10,200	-3,000 Reduced 18.75%	13,000 $39,000
Q2 2019 Aug 14, 2019	SELL	$0.97 - $1.42 $10,074 - $14,748	-10,386 Reduced 39.36%	16,000 $16,000
Q1 2019 May 14, 2019	BUY	$1.1 - $1.74 $12,249 - $19,376	11,136 Added 73.02%	26,386 $37,000
Q4 2018 Feb 13, 2019	SELL	$1.0 - $6.12 $2,700 - $16,524	-2,700 Reduced 15.04%	15,250 $15,000
Q3 2018 Nov 13, 2018	SELL	$6.03 - $11.24 $30,451 - $56,762	-5,050 Reduced 21.96%	17,950 $108,000
Q2 2018 Aug 14, 2018	BUY	$8.91 - $14.54 $204,930 - $334,420	23,000 New	23,000 $248,000

Others Institutions Holding CLSD

# of Institutions

Shares Held

12.1M

Call Options Held

54.7K

Put Options Held

50.7K

View Full List

About Clearside Biomedical, Inc.

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $65.6M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

More about CLSD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Clearside Biomedical, Inc. Transaction History